Shares of biopharmaceutical company Celldex Therapeutics, Inc. closed the Friday trading session with a gain of 9.45% on heavy volume.
CLDX stock price closed the day at $4.40 a share. CLDX has traded between a 52 week low of $2.91 and a 52 week high of $9.49 a share.
Celldex's Precision Targeted Immunotherapy Platform is used to develop treatments for cancer and other diseases. CLDX's immunotherapy platform includes a portfolio of monoclonal antibodies, antibody-drug conjugates, antibody-targeted vaccines, and immunomodulators to create disease specific drug candidates.
Celldex Therapeutics
